An antibacterial assay-guided isolation of the crude ethyl acetate extract from Ficus foveolata stems afforded four compounds, including a tetrahydronaphthalene lignanamide, foveolatamide (1), together with two known lignanamides, flavifloramide B (2) and N-trans-grossamide (3), and a known phenolic amide, N-trans-feruloyltyramine (4). The structures of these compounds were established on the basis of NMR spectroscopic and MS techniques. Among the isolated compounds, only 1 showed satisfactory antibacterial activities against Streptococcus pyogenes, with an MIC and MBC value of 45 µM. This is the first report of these four compounds from the stems of F. foveolata.
Ficus foveolata Wall. (Moraceae) is a scandent shrub that is widely distributed in Asia [1] . In Thailand, alcoholic extracts from F. foveolata stems have traditionally been used as a rejuvenating agent and a tonic [2] . In Nepal, the bark powders of F. foveolata have been used as a lactating agent [3] . Phytochemical studies of this plant have recently reported the presence of coumarins, flavonoids, phenolics, sesquiterpenes, triterpenenes, stilbenes, and steroids [4] [5] [6] [7] . Some of them possess interesting biological activities, such as being potent and selective butyrylcholinesterase inhibiters [7] , showing cytotoxicity against some cancer cell lines [5, 6] , and antibacterial activities [4] .
In this study, a new tetrahydronaphthalene lignanamide, named foveolatamide (1), was isolated from F. foveolata stems, along with two known lignanamides, flavifloramide B (2) and N-transgrossamide (3), and a known phenolic amide, N-transferuloyltyramine (4) . The antibacterial activities of 1-4 against Streptococcus pyogenes and S. mitis were determined.
The crude ethyl acetate extract from the stems of F. foveolata was fractionated by a combination of silica gel and Sephadex ® LH-20 columns, to afford a new compound (1) and three known compounds (2-4) ( Figure 1 ). Compound 1 was obtained as a yellow amorphous powder. The UV spectrum showed an absorption maximum at 277 nm, and its IR spectrum exhibited the characteristic absorption bands of hydroxyls (3377 cm -1 ), carbonyls (1658, 1612 cm -1 ), and aromatic rings (1515, 1457 cm -1 ). , as well as two amide carbonyl groups at δ C 175.0 and 173.7. These data indicated that 1 is an arylnaphthalene type lignanamide. Based on the HMQC and HMBC spectra, the planar structure of 1 was established as shown in Figure  2 . The HMBC correlation of H-1 with C-2, C-3, C-2'/C6', C-2a, C-4a, C-8a and C-5/C-8; of H-2 with C-1, C-2a and C-8a; of H-3 with C-4 and C-3a; of H-8" with C-2a, C-7" and C-1", together with those of H-8"' with C-3a, C-7"' and C-1"', established a tetrahydronaphthalene lignanamide in 1. The attachments of four methoxyl groups [δ H 3.76 (6H, s) with C-3'/5'; 3.78 (6H, s) with C-6/7] were exhibited according to the HMBC correlation of 3'/5'-OCH 3 and 6/7-OCH 3 , respectively. Furthermore, one oxygenated methine proton was located at C-4 by the HMBC correlation between the resonances at δ C 173.7 (C-3a) and δ H 4.89 (H-4). Finally, the relative configurations of 1 were assigned by its NOESY spectrum ( Figure 2 ), which showed clear correlations between H-1 (δ H 4.32, J = 7.5 Hz) and H-2 (δ H 3.68, J = 7.5 Hz), to indicate a relative cis configuration. In addition, the NOESY data of 1 showed correlations between H-4 (δ H 4.89, J = 4.5 Hz) and H-3 (δ H 2.65, J = 4.5 Hz) that indicated a relative trans configuration. 3 4 92 Natural Product Communications Vol. 11 (1) 2016 
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No correlation existed between H-1 and H-4, and between H-2 and
H-3 in the NOESY spectrum. The structure of 1 was therefore elucidated as rel-
By comparison of their NMR and MS data with the data reported previously, the three known compounds were identified as two lignanamides, flavifloramide B (2) [8] and N-trans-grossamide (3) [9, 10] , and a phenolic amide, N-trans-feruloyltyramine (4) [11, 12] .
Each of these four compounds (1) (2) (3) (4) were investigated for their antibacterial activities against Gram positive (Bacillus subtilis, Staphylococcus aureus, Streptococcus pyogenes, S. mutans, S. mitis) and Gram negative bacteria (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa) using the microdilution method. Only 1 and 2 inhibited S. pyogenes and S. mitis, while 3 and 4 inhibited only S. pyogenes (Table 2 ). Only 1 exhibited satisfactory antibacterial activity against S. pyogenes with MIC and MBC values of 45 µM. Neither of them exhibited inhibitory activity against B. subtilis, S. aureus, S. mutans, and all the Gram negative bacteria. However, it has been reported that some of these isolated compounds possess other interesting biological activities: e.g, 3 exhibited antitumor activity [13] , 4 showed anti-inflammatory [14] and antioxidant activities [15] , inhibited melanin biosynthesis [16] , and was also used as a marker for standardization of Smilax aristolochiifolia root extract that possessed hypoglycemic and hypotensive activities. Recently, 2 and 4 have also been isolated from the aerial parts of Piper flaviflorum, a medicinal plant used to treat some chronic and incurable diseases [8] . These findings may help to explain, in part, some of the claimed pharmacological activities of F. foveolata. 
Extraction and isolation:
The dried stems of F. foveolata (16 kg) were ground and extracted 5 times with EtOAc (20 L × 5) each using reflux conditions for 1 h. The combined extracts were then concentrated under reduced pressure to yield a dark brown extract (82 g). This (80 g) was subjected to silica gel vacuum chromatography eluted with a step-gradient of n-hexane-EtOAc (100:0, 50:50, 20:80, v/v), and EtOAc-MeOH (100:0, 90:10, 20:80, v/v) to give 7 fractions (fraction 1-7), which were then subjected to antibacterial assay. The antibacterial fraction 5 (5.7 g) was further fractionated using a silica gel column (7.5 × 60 cm), eluted with a step-gradient of n-hexane-EtOAc (80:20, 60:40, 40:60, 20:80, 0:100, v/v) and EtOAc-MeOH (90:10, 70:30, v/v) to give 7 fractions (fraction 5.1-5.7). These were then subjected to an antibacterial assay. The antibacterial fraction 5.5 (2.7 g) was further purified on a silica gel column (7.5 × 50 cm), eluted with a gradient of CHCl 3 -MeOH (100:0, 90:1, 80:2, 70:30, v/v) to afford 5
A new lignanamide from the stems of Ficus foveolata Natural Product Communications Vol. 11 (1) 2016 93 fractions (fraction I-V). The antibacterial fraction III (843 mg) was fractionated on a Sephadex LH-20 column (3 × 80 cm) using MeOH as an eluent to give 4 fractions (fraction A-D). The antibacterial fraction B (605 mg) was further purified on a silica gel column (2.5 × 12 cm), eluted with CHCl 3 -MeOH (96:4, v/v) to give 4 fractions (fraction B1-B4). The antibacterial fraction B3 (323 mg) was fractionated using a Sephadex LH-20 column (2.5 × 60) eluted with MeOH to give 6 fractions (fraction B3.1-B3.6). The antibacterial fraction B3.2 (103 mg) was further purified on a silica gel column (2.5 × 12 cm), eluted with a mixture of CHCl 3 -MeOH (98:2, 96:4, %v/v) to provide compounds 1 (22.2 mg) and 2 (9.5 mg).
The antibacterial fraction II (1 g) was further purified by a Sephadex LH-20 column (3 × 80 cm) using a mixture of CHCl 3 -MeOH (50:50, v/v) to give 5 fractions (fraction IIA-IIE). The antibacterial fraction IID (762 mg) was rechromatographed on Sephadex LH-20 eluting with MeOH to yield 5 fractions (fraction IID1-IID5). The antibacterial fraction IID4 (182 mg) was further purified on a silica gel column (2.5 × 12 cm) eluted with a mixture of n-hexane-EtOAc (40:60, v/v) to afford compounds 3 (34.1 mg) and 4 (24.0 mg). 
Foveolatamide
Determination of minimum inhibitory and bactericidal concentration:
The MIC and MBC were determined by the broth micro-dilution assay [17] . The MIC is defined as the lowest concentration of the compound to inhibit the growth of microorganisms, and the MBC is defined as the lowest concentration of the compound to kill the microorganisms. The compounds were diluted in DMSO to a concentration of 1000 µg/mL (stock solution) and serially diluted with media to concentrations between 0.1 and 500 µg/mL. DMSO was used as a negative control, while standard ampicillin was used as a positive control for antibacterial testing. The test was performed in 96-well plates. Two-fold dilutions were prepared directly in a 96-well plate, as follows: 50 µL of the working solution of compounds were added to well 1 of the dilution series. To each remaining well, 50 µL of BHI broth was added. With a sterile pipette tip, 50 µL of the mixture was transferred to well 2. This process was continued until the final concentration.
The inoculum was prepared in sterile physiological saline solution and adjusted to a turbidity of the 0.5 McFarland standard (1.5 × 10 8 cfu/mL). It was then further diluted 1:100 in sterile broth to contain 1.5 × 10 6 cfu/mL and 50 µL of the adjusted inoculum was added to each well then incubated as described above. The incubation mixtures that showed a positive inhibitory effect were streaked on BHI agar. The MBC was detected as the lowest concentration at which no colonies of test bacteria formed on the BHI medium.
